- Home
- GRX vs MXCT Comparison
GRX vs MXCT Comparison
Compare GRX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- MXCT
- Stock Information
- Founded
- GRX 2007
- MXCT 1999
- Country
- GRX United States
- MXCT United States
- Employees
- GRX N/A
- MXCT N/A
- Industry
- GRX Finance/Investors Services
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GRX Finance
- MXCT Health Care
- Exchange
- GRX Nasdaq
- MXCT Nasdaq
- Market Cap
- GRX 142.7M
- MXCT 159.9M
- IPO Year
- GRX N/A
- MXCT 2021
- Fundamental
- Price
- GRX $9.32
- MXCT $1.50
- Analyst Decision
- GRX
- MXCT Buy
- Analyst Count
- GRX 0
- MXCT 4
- Target Price
- GRX N/A
- MXCT $7.50
- AVG Volume (30 Days)
- GRX 39.7K
- MXCT 561.6K
- Earning Date
- GRX 01-01-0001
- MXCT 11-12-2025
- Dividend Yield
- GRX 5.98%
- MXCT N/A
- EPS Growth
- GRX N/A
- MXCT N/A
- EPS
- GRX 0.26
- MXCT N/A
- Revenue
- GRX N/A
- MXCT $35,754,000.00
- Revenue This Year
- GRX N/A
- MXCT N/A
- Revenue Next Year
- GRX N/A
- MXCT $14.72
- P/E Ratio
- GRX $38.50
- MXCT N/A
- Revenue Growth
- GRX N/A
- MXCT N/A
- 52 Week Low
- GRX $7.73
- MXCT $1.26
- 52 Week High
- GRX $10.40
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- GRX 55.32
- MXCT 45.66
- Support Level
- GRX $9.08
- MXCT $1.37
- Resistance Level
- GRX $9.32
- MXCT $1.71
- Average True Range (ATR)
- GRX 0.09
- MXCT 0.11
- MACD
- GRX -0.00
- MXCT -0.01
- Stochastic Oscillator
- GRX 85.19
- MXCT 42.25
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.